Wiesbaden, Germany

Velocity Clinical Research Germany GmbH

Founded in 1998 as Clinical Research Intermed GmbH and acquired by Velocity Clinical Research in 2023, the experienced team at Velocity’s dedicated research site in Wiesbaden conducts clinical trials across many areas of medicine, including chronic pain, pulmonology, the central nervous system (CNS), general medicine, and vaccines.

The Wiesbaden team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Velocity Clinical Research Germany GmbH
Hasengartenstr. 42, 65189, Wiesbaden, Germany

Phone: +49 (0)611-900590

Find a Clinical Trial in Wiesbaden
Browse current research studies in Wiesbaden on VelocityClinicalTrials.eu.

Wiesbaden Velocity Clinical Research Site exterior building

About Velocity Clinical Research

155,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Our experienced research team in Wiesbaden

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Wiesbaden is dedicated to conducting quality research in a professional and caring environment.

  • Mauricio Sendeski, MD, PhD

    Medical Director and Principal Investigator
    With over 18 years of experience in clinical research, including leading and managing clinical trials across multiple therapeutic areas, such as diabetes, cardiovascular risk, chronic pain, and neurological disorders, Dr. Mauricio Sendeski is a highly experienced medical professional with a robust background in clinical research and neurology.

    Dr. Sendeski holds a PhD in Experimental Pathophysiology and a Medical Degree in Neurosurgery from the University of São Paulo, Brazil. He began his medical career as a Staff Neurologist and Neurosurgeon at the Department of Neurology and Neurosurgery at São Paulo University, before transitioning into research and academia. His extensive experience includes roles as Site Manager and Principal Investigator at Accelerated Enrollment Solutions (AES) GmbH in Leipzig, Germany, and as Medical Manager at the Skills Lab of the Brandenburg Medical School in Neuruppin, Germany.

    In addition to his clinical research expertise, Dr. Sendeski has also contributed to medical education as a Senior Researcher and Physiology Lecturer at Charité – Medical University Berlin. He holds multiple certifications in Good Clinical Practice (GCP) and has been involved in a wide range of clinical trials, spanning Phase II to Phase IV studies.

  • Marco VonBehren

    Marco von Behren

    Site Director

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.